Evogene (EVGN) Non Operating Income (2013 - 2026)

Evogene has disclosed Non Operating Income across 14 years of filings, most recently posting $972000.0 for Q2 2026.

• In Q2 2026, Non Operating Income rose 391.89% year-over-year to $972000.0; the TTM figure through Jun 2026 stood at -$2.0 million (down 131.75% YoY), while the FY2025 annual figure was $777000.0, down 80.74% from the prior year.
• Non Operating Income came in at $972000.0 for Q2 2026 at Evogene, up from -$2.7 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $4.5 million in Q4 2024 to a low of -$2.7 million in Q1 2026.
• Average Non Operating Income over 5 years is $441555.6, with a median of $120500.0 recorded in 2023.
• Year-over-year, Non Operating Income surged 8690.2% in 2024 and plunged 443.3% in 2025.
• Over 5 years, Non Operating Income stood at -$149000.0 in 2022, then surged by 134.23% to $51000.0 in 2023, then surged by 8690.2% to $4.5 million in 2024, then tumbled by 103.77% to -$169000.0 in 2025, then surged by 675.15% to $972000.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $972000.0 in Q2 2026, -$2.7 million in Q1 2026, and -$169000.0 in Q4 2025.